Amelioration of NK cell function driven by V alpha 24(+) invariant NKT cell activation in multiple myeloma

摘要

NK cells represent a first line of immune defense, but are progressively dysregulated in multiple myeloma (MM) patients. To restore and facilitate their antitumor effect, NK cells are required in sufficient quantities and must be stimulated. We initially assessed the proportions of NKT and NK cells in 34 MM patients. The frequencies of both in PBMC populations correlated with those in BMMNCs irrespective of low BMMNC numbers. We then assessed the adjunctive effect of stimulating NKT cells with CD1d and alpha-GalCer complexes on the NK cells. The expression of NKG2D on CDS6(dim)CD16(+) NK cells and DNAM-1 on CD56(bright)CD16(-) NK cells increased after NKT cell activation. Apparently. NK cell-mediated anti-tumor effects were dependent on NKG2D and DNAM-1 ligands on myeloma cells. Thus, NK cell function in patients could be ameliorated, beyond the effect of immunosuppression, by NKT cell activation. This NKT-driven NK cell therapy could represent a potential new treatment modality. (C) 2017 Elsevier Inc. All rights reserved.